This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1994 May;25(5):435-7.

doi: 10.1016/0046-8177(94)90113-9.

p53 immunohistochemistry: a word of caution

PMID: 8200635
DOI: 10.1016/0046-8177(94)90113-9

Editorial

p53 immunohistochemistry: a word of caution

H Battifora. Hum Pathol. 1994 May.

. 1994 May;25(5):435-7.

doi: 10.1016/0046-8177(94)90113-9.

Author

PMID: 8200635
DOI: 10.1016/0046-8177(94)90113-9

No abstract available

PubMed Disclaimer

Comment on

Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations.
Kennedy SM, Macgeogh C, Jaffe R, Spurr NK. Kennedy SM, et al. Hum Pathol. 1994 May;25(5):438-42. doi: 10.1016/0046-8177(94)90114-7. Hum Pathol. 1994. PMID: 8200636
p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens.
Cagle PT, Brown RW, Lebovitz RM. Cagle PT, et al. Hum Pathol. 1994 May;25(5):443-8. doi: 10.1016/0046-8177(94)90115-5. Hum Pathol. 1994. PMID: 8200637
Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data.
Xerri L, Bouabdallah R, Camerlo J, Hassoun J. Xerri L, et al. Hum Pathol. 1994 May;25(5):449-54. doi: 10.1016/0046-8177(94)90116-3. Hum Pathol. 1994. PMID: 8200638

Similar articles

Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
Dix B, Robbins P, Carrello S, House A, Iacopetta B. Dix B, et al. Br J Cancer. 1994 Oct;70(4):585-90. doi: 10.1038/bjc.1994.355. Br J Cancer. 1994. PMID: 7917901 Free PMC article.
Mutational spectra and immunohistochemical analyses of p53 in human cancers.
Bennett WP, Hollstein MC, Hsu IC, Sidransky D, Lane DP, Vogelstein B, Harris CC. Bennett WP, et al. Chest. 1992 Mar;101(3 Suppl):19S-20S. doi: 10.1378/chest.101.3_supplement.19s. Chest. 1992. PMID: 1541189 No abstract available.
p53 protein detected by immunohistochemical staining is not always mutant.
MacGeoch C, Barnes DM, Newton JA, Mohammed S, Hodgson SV, Ng M, Bishop DT, Spurr NK. MacGeoch C, et al. Dis Markers. 1993 Dec;11(5-6):239-50. doi: 10.1155/1993/480686. Dis Markers. 1993. PMID: 8082313
[To study protein p53. Why, how?].
Fléjou JF, Laurent-Puig P. Fléjou JF, et al. Ann Pathol. 1995;15(3):165-7. Ann Pathol. 1995. PMID: 7639851 Review. French. No abstract available.
P53 abnormalities and outcomes in colorectal cancer: a systematic review.
Smith FM, Stephens RB, Kennedy MJ, Reynolds JV. Smith FM, et al. Br J Cancer. 2005 May 9;92(9):1813. doi: 10.1038/sj.bjc.6602589. Br J Cancer. 2005. PMID: 15856032 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma.
Segers K, Backhovens H, Singh SK, De Voecht J, Ramael M, Van Broeckhoven C, Van Marck E. Segers K, et al. Virchows Arch. 1995;427(4):431-6. doi: 10.1007/BF00199393. Virchows Arch. 1995. PMID: 8548129
Prognostic markers for colorectal cancer: expression of P53 and BCL2.
Pereira H, Silva S, Julião R, Garcia P, Perpétua F. Pereira H, et al. World J Surg. 1997 Feb;21(2):210-3. doi: 10.1007/s002689900218. World J Surg. 1997. PMID: 8995081 Clinical Trial.
Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.
Konishi N, Hiasa Y, Matsuda H, Tao M, Tsuzuki T, Hayashi I, Kitahori Y, Shiraishi T, Yatani R, Shimazaki J, et al. Konishi N, et al. Am J Pathol. 1995 Oct;147(4):1112-22. Am J Pathol. 1995. PMID: 7573356 Free PMC article.
Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood.
Schiffer D, Cavalla P, Di Sapio A, Giordana MT, Mauro A. Schiffer D, et al. Childs Nerv Syst. 1995 Sep;11(9):517-22. doi: 10.1007/BF00822841. Childs Nerv Syst. 1995. PMID: 8529218
Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma.
Doak SH, Jenkins GJ, Parry EM, Griffiths AP, Shah V, Baxter JN, Parry JM. Doak SH, et al. Br J Cancer. 2003 Nov 3;89(9):1729-35. doi: 10.1038/sj.bjc.6601323. Br J Cancer. 2003. PMID: 14583777 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal